Edwards Lifesciences Corporation Derivative Asset, Noncurrent
Edwards Lifesciences Corporation (EW) had Derivative Asset, Noncurrent of $14.60 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DerivativeAssetsNoncurrent · last filed 2026-08-04
- 2026-06-30: Derivative Asset, Noncurrent $14.60M.
- 2026-03-31: Derivative Asset, Noncurrent $14.20M.
- 2025-12-31: Derivative Asset, Noncurrent $5.80M.
- 2025-09-30: Derivative Asset, Noncurrent $5.10M.
| Period end | Derivative Asset, Noncurrent |
|---|---|
| 2026-06-30 | $14.60M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $14.20M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $5.80M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $5.10M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $3.10M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $26.60M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $34.70M 10-K · filed 2026-02-25 |
| 2024-09-30 | $21.80M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $30.50M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $27.90M 10-Q · filed 2024-04-29 |
| 2023-12-31 | $23.40M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |